Healthcare -
Biotechnology - NASDAQ - US
$ 4.38
-1.13 %
$ 265 M
Market Cap
-3.56
P/E
Price Target
Average
208.22%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
31.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rezolute, Inc.
Wall Street analysts predict an average 1-year price target for RZLT of $13.5 , with forecasts ranging from
a
low of
$11 to a high of $15 .
RZLT Lowest Price Target
Wall Street Target
11 USD
151.14%
RZLT Average Price Target
Wall Street Target
13.5 USD
208.22%
RZLT Highest Price Target
Wall Street Target
15 USD
242.47%
REVENUE FORECAST
Revenue Forecast Chart RZLT
EBIT FORECAST
EBIT Forecast Chart RZLT
NET INCOME FORECAST
Net Income Chart RZLT